CODX vs OGN
Co-Diagnostics, Inc. Common Stock (CODX) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CODX currently screens at market cap $31.4M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CODX and OGN stock pages for the full models.
Not investment advice.